Margaret A. Alexander insider trades

Open-market stock purchases and sales by Margaret A. Alexander, President and CEO at Ovid Therapeutics Inc, from SEC Form 4 filings since Sep 9, 2024.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +256%.

Recent trades

DateStockTradeValue
Feb 26, 2026OVID Ovid Therapeutics IncBought (not open market)—
Feb 23, 2026OVID Ovid Therapeutics IncSold$16.9K
Jan 4, 2026OVID Ovid Therapeutics IncBought (not open market)—

Companies traded

  • OVID Ovid Therapeutics Inc: 1 buy, 2 sales, last Feb 26, 2026

Get free alerts when Margaret A. Alexander files a new trade →